Antiretroviral Drug Interactions: Overview of Interactions Involving New and Investigational Agents and the Role of Therapeutic Drug Monitoring for Management

By Rathbun R. Chris   Liedtke Michelle D.  

Pharmaceutics, Vol. 3, Iss. 4, 2011-10 ,pp. : 745-781

MDPI

Access to resources Recommend Favorite

Current Perspectives on HIV-1 Antiretroviral Drug Resistance

By Iyidogan Pinar   Anderson Karen S.  

Viruses, Vol. 6, Iss. 10, 2014-10 ,pp. : 4095-4139

MDPI

Access to resources Recommend Favorite

High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia

By Tadesse Birkneh Tilahun   Kinloch Natalie N.   Baraki Bemuluyigza   Lapointe Hope R.   Cobarrubias Kyle D.   Brockman Mark A.   Brumme Chanson J.   Foster Byron A.   Jerene Degu   Makonnen Eyasu   Aklillu Eleni   Brumme Zabrina L.  

Viruses, Vol. 10, Iss. 2, 2018-02 ,pp. : 60-60

MDPI

Access to resources Recommend Favorite

Darunavir: A Critical Review of Its Properties, Use and Drug Interactions

By  

Pharmacology, Vol. 90, Iss. 1-2, 2012-07 ,pp. : 102-109

Karger

Access to resources Recommend Favorite

Review of Tolvaptan’s Pharmacokinetic and Pharmacodynamic Properties and Drug Interactions

By Bhatt Purav R.   McNeely Elizabeth B.   Lin Tess E.   Adams Kirkwood F.   Patterson J. Herbert  

Journal of Clinical Medicine, Vol. 3, Iss. 4, 2014-11 ,pp. : 1276-1290

MDPI

Access to resources Recommend Favorite